Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 401: Which of the following immunosuppressive agents has a side effect of osteoporosis?

A. Cyclophosphamide
B. Methotrexate
C. Glucocorticoids (Correct Answer)
D. Mycophenolate mofetil

Explanation: **Explanation:** **Glucocorticoids** (Option C) are the primary cause of drug-induced osteoporosis. They induce bone loss through a multi-factorial mechanism: 1. **Direct Inhibition:** They inhibit osteoblast (bone-forming cells) activity and increase osteoclast (bone-resorbing cells) lifespan. 2. **Calcium Homeostasis:** They decrease intestinal calcium absorption and increase renal calcium excretion. 3. **Hormonal Impact:** They suppress the gonadotropin-releasing hormone, leading to lower levels of estrogen and testosterone, which are essential for maintaining bone density. **Analysis of Incorrect Options:** * **Cyclophosphamide (Option A):** An alkylating agent primarily known for **hemorrhagic cystitis** (prevented by Mesna) and gonadotoxicity. While it can cause premature menopause (leading to secondary bone loss), it is not directly osteoporotic like steroids. * **Methotrexate (Option B):** An antimetabolite (DHFR inhibitor). Its hallmark toxicities include **myelosuppression**, hepatotoxicity, and pulmonary fibrosis. "Methotrexate osteopathy" is rare and typically only seen with high-dose chemotherapy, not standard immunosuppressive doses. * **Mycophenolate Mofetil (Option D):** An IMPDH inhibitor used in transplants. Its main side effects are **gastrointestinal distress** (diarrhea) and bone marrow suppression. It does not affect bone mineral density. **NEET-PG High-Yield Pearls:** * **Glucocorticoid-Induced Osteoporosis (GIOP):** It is the most common cause of secondary osteoporosis. Bone loss is most rapid in the first 6 months of therapy. * **Prophylaxis:** Patients on long-term steroids (>3 months) should be started on **Bisphosphonates** (e.g., Alendronate) along with Calcium and Vitamin D supplements. * **Other Steroid Side Effects:** Cushingoid features, hyperglycemia, cataracts, avascular necrosis of the femoral head, and psychosis.

Question 402: Pink disease or acrodynia is seen with exposure to which of the following?

A. Arsenic
B. Mercury (Correct Answer)
C. Copper
D. Lead

Explanation: **Explanation:** **Pink disease**, also known as **Acrodynia**, is a hypersensitivity reaction (Type IV) occurring primarily in children exposed to **Mercury** (elemental or inorganic). Historically, it was associated with the use of calomel in teething powders and mercurial ointments. **Why Mercury is correct:** The condition is characterized by a distinctive clinical triad: 1. **Dermatological:** Pinkish discoloration of the hands and feet (hence the name), accompanied by desquamation and painful swelling. 2. **Neurological:** Irritability, photophobia, and hypotonia. 3. **Autonomic:** Profuse sweating (diaphoresis) and hypertension due to mercury’s interference with the catecholamine degradation pathway (COMT inhibition). **Why other options are incorrect:** * **Arsenic:** Chronic poisoning typically presents with "raindrop" pigmentation, hyperkeratosis of palms/soles, and Mees' lines on nails. It is associated with lung and skin cancers (Bowen’s disease). * **Copper:** Excess accumulation leads to **Wilson’s Disease**, characterized by Kayser-Fleischer (KF) rings in the cornea and basal ganglia degeneration. * **Lead:** Chronic toxicity (Plumbism) presents with microcytic anemia (basophilic stippling), "Burtonian lines" on gums, and wrist/foot drop due to peripheral neuropathy. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment of choice for Acrodynia:** Dimercaprol (BAL) or Succimer (DMSA). * **Minamata Disease:** Caused by organic mercury (Methylmercury) consumption via contaminated fish. * **Erethism:** A neuropsychiatric syndrome (shyness, tremors, irritability) seen in chronic mercury vapor inhalation, historically known as "Mad Hatter’s Syndrome."

Question 403: What is the treatment of choice for opioid poisoning?

A. Oral naltrexone
B. Intravenous naloxone (Correct Answer)
C. Oral diazepam
D. Oral buprenorphine

Explanation: **Explanation:** **1. Why Intravenous Naloxone is the Correct Answer:** Opioid poisoning is a medical emergency characterized by the "classic triad": respiratory depression, pinpoint pupils (miosis), and coma. **Naloxone** is a pure opioid antagonist that competes for $\mu$, $\kappa$, and $\delta$ receptors, rapidly reversing the life-threatening respiratory depression. In an acute emergency, the **intravenous (IV)** route is preferred because it provides the fastest onset of action (1–2 minutes). **2. Why the Other Options are Incorrect:** * **Oral Naltrexone:** While naltrexone is also an opioid antagonist, it has a long duration of action and is primarily used for the **maintenance of abstinence** in recovered addicts. Its oral administration and slow onset make it unsuitable for acute toxicity. * **Oral Diazepam:** Diazepam is a benzodiazepine (sedative-hypnotic). Administering it in opioid poisoning would worsen CNS and respiratory depression, potentially leading to death. * **Oral Buprenorphine:** This is a partial $\mu$-agonist. While used in opioid substitution therapy, it can precipitate withdrawal in dependent individuals and will not effectively reverse a massive overdose. **3. High-Yield Clinical Pearls for NEET-PG:** * **Short Half-life:** Naloxone has a shorter half-life (approx. 60–90 mins) than most opioids (e.g., Morphine, Methadone). Therefore, **repeated dosing or a continuous IV infusion** is often required to prevent "re-narcotization." * **Diagnostic Use:** Naloxone is used in the "Coma Cocktail" for patients with an unknown cause of unconsciousness. * **Withdrawal:** In opioid-dependent patients, naloxone can precipitate an acute, severe withdrawal syndrome (shivering, gooseflesh, lacrimation). * **Exception:** Mydriasis (dilated pupils) rather than miosis is seen in **Pethidine** poisoning due to its atropine-like action.

Question 404: What is the antidote for Alprazolam?

A. Protamine sulphate
B. Flumazenil (Correct Answer)
C. EDTA
D. BAL

Explanation: **Explanation:** **Correct Answer: B. Flumazenil** Alprazolam is a **Benzodiazepine (BZD)** [3]. Benzodiazepines work by enhancing the effect of GABA (the primary inhibitory neurotransmitter) at the GABA-A receptor by increasing the frequency of chloride channel opening [4]. **Flumazenil** is a competitive antagonist at the benzodiazepine binding site on the GABA-A receptor complex [1], [2]. It rapidly reverses the sedative effects of BZDs, making it the specific antidote for overdose or for reversing conscious sedation [1]. **Incorrect Options:** * **A. Protamine sulphate:** This is the specific antidote for **Heparin** overdose. It is a positively charged molecule that neutralizes negatively charged heparin through ionic bonding. * **C. EDTA (Ethylenediaminetetraacetic acid):** This is a chelating agent used primarily for **Lead poisoning**. * **D. BAL (British Anti-Lewisite/Dimercaprol):** This is a chelating agent used for heavy metal poisoning, specifically **Arsenic, Mercury, and Gold**. **High-Yield Clinical Pearls for NEET-PG:** * **Seizure Risk:** The most significant risk of administering Flumazenil is the precipitation of **seizures**, especially in patients with chronic BZD dependence or co-ingestion of TCAs (Tricyclic Antidepressants) [2]. * **Short Half-life:** Flumazenil has a very short half-life (approx. 1 hour). Since most BZDs (like Diazepam) last longer, **resedation** can occur, requiring repeated doses or a continuous infusion. * **Mechanism Reminder:** BZDs increase the *frequency* of channel opening, while Barbiturates increase the *duration*. Flumazenil does **not** reverse Barbiturate toxicity [1].

Question 405: Regarding adverse reactions of anticonvulsants, all are true EXCEPT:

A. Phenobarbitone - Cardiovascular defect
B. Carbamazepine - Breech presentation (Correct Answer)
C. Phenytoin - Gum hyperplasia
D. Sodium valproate - Neural tube defect

Explanation: **Explanation:** This question tests knowledge of the teratogenic and systemic adverse effects of common antiepileptic drugs (AEDs). **1. Why Option B is the Correct Answer:** **Carbamazepine** is associated with **Neural Tube Defects (NTDs)**, craniofacial abnormalities, and fingernail hypoplasia. **Breech presentation** is a mechanical obstetric complication related to fetal positioning and is **not** a drug-induced malformation or a recognized adverse effect of Carbamazepine. Therefore, this statement is false. **2. Analysis of Incorrect Options (True Statements):** * **A. Phenobarbitone - Cardiovascular defect:** Phenobarbitone is a known teratogen. Maternal use is associated with congenital heart diseases (e.g., septal defects) and the "Fetal Hydantoin-like Syndrome." * **C. Phenytoin - Gum hyperplasia [1]:** This is a classic, high-yield side effect occurring in about 50% of patients. It is caused by the stimulation of platelet-derived growth factor (PDGF) and fibroblast proliferation. * **D. Sodium valproate - Neural tube defect:** Valproate has the highest teratogenic risk among AEDs. It interferes with folate metabolism, leading specifically to **spina bifida** (incidence ~1-2%). **3. High-Yield Clinical Pearls for NEET-PG:** * **Fetal Hydantoin Syndrome (Phenytoin):** Characterized by cleft lip/palate, microcephaly, and hypoplastic phalanges/nails. * **Valproate:** Most common cause of NTDs; supplementation with high-dose Folic Acid (5mg) is mandatory for women of childbearing age on AEDs. * **Drug of Choice (DOC) in Pregnancy:** **Lamotrigine** and **Levetiracetam** are currently considered the safest AEDs regarding major malformations. * **Enzyme Induction:** Phenytoin, Carbamazepine, and Phenobarbital are potent **CYP450 inducers**, which can lead to Vitamin K deficiency in the neonate (causing hemorrhagic disease of the newborn).

Question 406: What is the mechanism of action of ethanol in methyl alcohol poisoning?

A. Competitively inhibits alcohol dehydrogenase (Correct Answer)
B. Selectively inhibits catalase
C. Competitively inhibits lactate dehydrogenase
D. Competitive inhibition of acetaldehyde dehydrogenase

Explanation: ### Explanation **Mechanism of Action (Correct Answer: A)** Methanol (wood alcohol) itself is relatively non-toxic; however, it is metabolized in the liver by the enzyme **Alcohol Dehydrogenase (ADH)** into **formaldehyde**, which is then rapidly converted by aldehyde dehydrogenase into **formic acid**. Formic acid is the toxic metabolite responsible for metabolic acidosis and retinal damage (blindness). Ethanol acts as a specific antidote because it has a **10–20 times higher affinity** for Alcohol Dehydrogenase than methanol. By **competitively inhibiting ADH**, ethanol prevents the conversion of methanol into its toxic metabolites. This allows methanol to be excreted unchanged by the kidneys or lungs. **Analysis of Incorrect Options** * **B. Selectively inhibits catalase:** Catalase plays a minor role in alcohol metabolism in humans; inhibiting it would not prevent the formation of toxic formic acid via the primary ADH pathway. * **C. Competitively inhibits lactate dehydrogenase:** LDH is involved in converting pyruvate to lactate. While methanol poisoning causes lactic acidosis (due to mitochondrial inhibition by formic acid), ethanol does not act on this enzyme. * **D. Competitive inhibition of acetaldehyde dehydrogenase:** This is the mechanism of **Disulfiram**. Inhibiting this enzyme during methanol poisoning would be counterproductive as it would lead to the accumulation of formaldehyde. **Clinical Pearls for NEET-PG** * **Fomepizole:** The preferred modern antidote for methanol/ethylene glycol poisoning. It is a potent competitive inhibitor of ADH and is preferred over ethanol because it does not cause CNS depression or hypoglycemia. * **Target Ethanol Level:** In treatment, blood ethanol levels should be maintained between **100–150 mg/dL**. * **Cofactor Therapy:** **Folic acid** (or leucovorin) is administered to enhance the breakdown of formic acid into CO₂ and water. * **Classic Presentation:** "Snowstorm vision" (retinal edema) and high anion gap metabolic acidosis (HAGMA).

Question 407: What is the condition known as "Blue Man Syndrome"?

A. Acrodynia
B. Argyria (Correct Answer)
C. Plumbism
D. None of the above

Explanation: **Explanation:** **Argyria (Option B)** is the correct answer. It is a rare clinical condition caused by chronic exposure to or ingestion of **silver salts**. Silver particles deposit in the skin, mucous membranes, and internal organs. Upon exposure to sunlight, these silver deposits undergo a photochemical reaction (similar to photography), resulting in a characteristic, irreversible **slate-grey to bluish discoloration** of the skin, often referred to as **"Blue Man Syndrome."** **Analysis of Incorrect Options:** * **Acrodynia (Option A):** Also known as "Pink Disease," this is a manifestation of chronic **mercury poisoning**, primarily seen in children. It presents with pinkish discoloration of the hands and feet, irritability, and polyneuropathy, rather than blue skin. * **Plumbism (Option C):** This is the medical term for **lead poisoning**. Clinical hallmarks include the "Burtonian line" (bluish-purple line on the gums), abdominal colic, wrist drop/foot drop, and microcytic hypochromic anemia with basophilic stippling. It does not cause generalized blue skin. **High-Yield Clinical Pearls for NEET-PG:** * **Amiodarone:** This anti-arrhythmic drug is a common pharmacological cause of **"Blue-grey skin pigmentation"** due to iodine deposits and lipofuscin accumulation in the skin. * **Differential Diagnosis:** Always differentiate Blue Man Syndrome from **Methemoglobinemia**, where the skin appears cyanotic/blue due to oxidized hemoglobin (Fe³⁺) which cannot bind oxygen. * **Treatment of Argyria:** There is no effective systemic cure; treatment is primarily preventive. Laser therapy (Q-switched Nd:YAG) has shown some success in reducing skin pigmentation.

Question 408: Which drug causes Addison's disease?

A. Ketoconazole (Correct Answer)
B. Aminoglutethimide
C. Cyclosporine
D. Glucocorticoids

Explanation: **Explanation:** **Ketoconazole** is the correct answer because it is a potent inhibitor of steroidogenesis. It inhibits several cytochrome P450 enzymes, most notably **11β-hydroxylase** and **17,20-lyase**, which are essential for the synthesis of cortisol and adrenal androgens. Prolonged or high-dose use can lead to primary adrenal insufficiency, clinically manifesting as **Addison’s disease**. **Analysis of Options:** * **Ketoconazole (A):** Directly blocks cortisol synthesis. While used therapeutically to treat Cushing’s syndrome, its side effect profile includes adrenal suppression and hepatotoxicity. * **Aminoglutethimide (B):** While it inhibits the conversion of cholesterol to pregnenolone (blocking all steroid synthesis), it is primarily used to treat breast cancer or Cushing’s. However, in the context of standard NEET-PG questions, Ketoconazole is the classic prototype drug cited for causing clinical adrenal insufficiency. * **Cyclosporine (C):** This is an immunosuppressant (calcineurin inhibitor). Its primary toxicities are nephrotoxicity and gingival hyperplasia, not adrenal suppression. * **Glucocorticoids (D):** Chronic administration causes **Secondary Adrenal Insufficiency** (due to HPA axis suppression) upon abrupt withdrawal. It does not cause Addison’s disease (Primary Adrenal Insufficiency) while the drug is being administered; rather, it causes Cushingoid features. **High-Yield Clinical Pearls for NEET-PG:** * **Ketoconazole** also causes **Gynecomastia** and decreased libido in males due to the inhibition of androgen synthesis. * **Drug of choice for Cushing’s Syndrome:** Ketoconazole is often the preferred medical management to rapidly lower cortisol levels. * **Etomidate:** An intravenous anesthetic agent that also inhibits 11β-hydroxylase and can cause transient adrenal suppression after a single dose.

Question 409: A herpetologist is bitten by a poisonous snake and is taken to the emergency department with progressive muscle paralysis. The venom is probably affecting which of the following?

A. Na+ channels
B. Ca2+ channels
C. Phospholipids
D. Acetylcholine receptors (Correct Answer)

Explanation: **Explanation:** The clinical presentation of progressive muscle paralysis following a snake bite is characteristic of **neurotoxic envenomation**, most commonly associated with Elapids (e.g., Cobra, Krait). **Why Acetylcholine (ACh) receptors are the correct answer:** Neurotoxic venoms contain toxins that interfere with neuromuscular transmission. These toxins are categorized into two types: 1. **Post-synaptic neurotoxins (e.g., $\alpha$-bungarotoxin):** These bind irreversibly to **Nicotinic Acetylcholine Receptors (nAChR)** at the motor endplate, acting as competitive antagonists. This prevents ACh from binding, leading to flaccid paralysis. 2. **Pre-synaptic neurotoxins (e.g., $\beta$-bungarotoxin):** These inhibit the release of ACh from the nerve terminal. In both scenarios, the primary target of the functional blockade leading to paralysis is the cholinergic pathway. **Analysis of Incorrect Options:** * **A. Na+ channels:** While some toxins (like Tetrodotoxin or Saxitoxin) target sodium channels, common neurotoxic snake venoms specifically target the neuromuscular junction rather than axonal conduction. * **B. Ca2+ channels:** These are targeted by certain spider venoms or heavy metals, but not typically by the paralytic toxins of common venomous snakes. * **C. Phospholipids:** Many snake venoms contain **Phospholipase A2**, which causes local tissue necrosis and hemotoxicity (common in Viper bites), but it is not the primary mechanism for acute progressive muscle paralysis. **NEET-PG High-Yield Pearls:** * **Elapidae (Cobra/Krait):** Primarily neurotoxic (paralysis, ptosis, respiratory failure). * **Viperidae (Viper):** Primarily vasculotoxic (bleeding, DIC, local edema). * **Antidote:** Neostigmine (an AChE inhibitor) is often used in Cobra bites to increase ACh levels at the synapse and outcompete the toxin, though it is less effective for Krait bites. * **Early Sign:** Ptosis (drooping of eyelids) is usually the first clinical sign of neurotoxic snake bite.

Question 410: Why is therapeutic drug monitoring of theophylline clinically used in asthma?

A. It has a narrow therapeutic margin. (Correct Answer)
B. It causes idiosyncrasy.
C. It is nephrotoxic.
D. It decreases histamine.

Explanation: ### Explanation **1. Why Option A is Correct:** Theophylline is a methylxanthine derivative used as a bronchodilator [1]. The primary reason for Therapeutic Drug Monitoring (TDM) is its **narrow therapeutic index (margin)**. The therapeutic range for theophylline is typically **10–20 µg/mL**. * **Sub-therapeutic levels (<10 µg/mL):** Lead to poor control of asthma/COPD symptoms. * **Toxic levels (>20 µg/mL):** Lead to severe adverse effects like cardiac arrhythmias [1], persistent vomiting, and generalized seizures. Furthermore, its metabolism is highly variable due to hepatic CYP1A2 saturation (zero-order kinetics at high doses) and is influenced by factors like smoking, age, and drug interactions (e.g., Ciprofloxacin, Erythromycin). **2. Why Other Options are Incorrect:** * **Option B (Idiosyncrasy):** Idiosyncratic reactions are unpredictable, genetically determined abnormal responses (e.g., G6PD deficiency). TDM is used for predictable, dose-dependent toxicity, not idiosyncratic ones. * **Option C (Nephrotoxic):** Theophylline is not primarily nephrotoxic. Its major toxicities are neurological (seizures) and cardiovascular (tachyarrhythmias) [1]. Drugs like Aminoglycosides or Amphotericin B require TDM due to nephrotoxicity. * **Option D (Decreases Histamine):** While theophylline has some anti-inflammatory effects and inhibits mediator release [2], this is a mechanism of action, not a reason for monitoring blood levels. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Phosphodiesterase (PDE) inhibition (increases cAMP) and Adenosine receptor antagonism [2]. * **Kinetics:** Follows **First-order kinetics** at therapeutic doses but shifts to **Zero-order kinetics** (Capacity-limited metabolism) at higher concentrations. * **Drug Interactions:** * **Enzyme Inducers (e.g., Smoking, Rifampicin, Phenytoin):** Decrease theophylline levels. * **Enzyme Inhibitors (e.g., Cimetidine, Erythromycin, Ciprofloxacin):** Increase theophylline levels, leading to toxicity. * **Antidote for Toxicity:** There is no specific pharmacological antagonist; management involves gastric lavage, activated charcoal, and hemodialysis in severe cases.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free